Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 18, 2021

SELL
$5.53 - $9.28 $30,415 - $51,040
-5,500 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$7.84 - $12.6 $43,120 - $69,300
5,500 New
5,500 $49,000
Q1 2020

Apr 17, 2020

SELL
$10.08 - $27.21 $257,040 - $693,855
-25,500 Closed
0 $0
Q4 2019

Jan 17, 2020

BUY
$13.05 - $21.88 $332,775 - $557,940
25,500 New
25,500 $513,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.